相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial
Karyn A. Goodman et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Updates in staging and pathologic evaluation of esophageal carcinoma following neoadjuvant therapy
Xuchen Zhang et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2020)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Esophageal and Esophagogastric Junction Cancers, Version 2.2019
Jaffer A. Ajani et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Prognostic relevance of tumor response after neoadjuvant therapy for patients with esophageal cancer
Elfriede Bollschweiler et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma
Moritz Jesinghaus et al.
BRITISH JOURNAL OF CANCER (2019)
Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?
Katharina Puetz et al.
HISTOPATHOLOGY (2019)
Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery
Milan Vosmik et al.
PATHOLOGY & ONCOLOGY RESEARCH (2018)
Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment Comparisons With WHO/ISUP Grade and Integrated Staging Systems
Jerome Verine et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer
Victor Wai Kwan Lee et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Prognostic factors in esophageal cancer treated with curative intent
Veronique Vendrely et al.
DIGESTIVE AND LIVER DISEASE (2018)
Survival outcomes from CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.
Karyn A. Goodman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.
Karyn A. Goodman et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer
P. S. Venkat et al.
DISEASES OF THE ESOPHAGUS (2017)
Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies
G. Tomasello et al.
EJSO (2017)
Cancer of the Esophagus and Esophagogastric Junction-Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual
Thomas W. Rice et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals
T. W. Rice et al.
DISEASES OF THE ESOPHAGUS (2016)
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T. Valentin et al.
EUROPEAN JOURNAL OF CANCER (2016)
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET ONCOLOGY (2016)
Endoscopic ultrasound-guided fiducial marker placement for image-guided radiation therapy without fluoroscopy: safety and technical feasibility
Gautamy Chitiki Dhadham et al.
ENDOSCOPY INTERNATIONAL OPEN (2016)
Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries
Maria Jose Domper Arnal et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer
J. Freilich et al.
DISEASES OF THE ESOPHAGUS (2015)
Prognostic Classification of Histopathologic Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Arnulf H. Hoelscher et al.
ANNALS OF SURGERY (2014)
Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor
Katja Ott et al.
LANGENBECKS ARCHIVES OF SURGERY (2013)
Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy
Daniel C. Fernandez et al.
PRACTICAL RADIATION ONCOLOGY (2013)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers
Matthew Brown et al.
HISTOPATHOLOGY (2010)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
